Google
CCEL Stock Price & Analysis — Cryocell International Inc (Healthcare >> Medical Care Facilities)
CCEL FAQ
What is CCEL's P/E ratio?
Cryocell International Inc (CCEL) currently trades at a P/E ratio of 13.19.
What is CCEL's ROE?
Cryocell International Inc reports a Return on Equity (ROE) of 13.89%.
What is CCEL's dividend yield?
Cryocell International Inc offers a dividend yield of 0.00%.
What is CCEL's Quality Score?
Our AI rates CCEL's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy CCEL?
Our AI Timing Score for CCEL is 3 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does CCEL belong to?
Cryocell International Inc is classified under the Healthcare >> Medical Care Facilities sector on the NYSE MKT exchange
CCEL AI Analysis Summary
Our AI summary for CCEL: Cryocell International Inc (NYSE MKT), Healthcare >> Medical Care Facilities sector. The stock currently trades at a P/E of 13.19, ROE of 13.89%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 3/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 3.64
Price
0.08
(2.25%)
Day Change
|
|
|---|
CCEL, the overall quality is not good ( Quality = 31) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
39% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 92 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 3.64 |
| PBV / Sector |
-1.65 / 2.75
|
| Earning Per Share | -0.31 |
| PE / Sector |
13.19 / 23.53
|
| PEG or PE/Growth / Sector |
-0.03 / 1.35
|
| Average 1M Daily Value |
0.03 M
GREAT
|
| Average 1W Daily Value |
0.03 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
41% |
| Ability to Make Profit |
|
56% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-08-06 07:59:46 |
| Symbol | CCEL |
| Name | CRYOCELL INTERNATIONAL INC |
| Sector | Healthcare >> Medical Care Facilities |
| Market | NYSE MKT |
| Listed Shares | 8.06 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 29.35 / 7,399.39 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 700 Brooker Creek Boulevard, Oldsmar, FL, United States, 34677
Phone: 813 749 2100
Website: https://www.cryo-cell.com
Employees: 72
Description: Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Care Facilities
Click a bubble to view stock details · Bubble size represents market capitalization share
